SAN DIEGO--(BUSINESS WIRE)--Aries Pharmaceuticals, Inc. (Aries) today announced the launch and commercial availability of its first product, Eleview™, a novel, ready to use, submucosal injectable ...
SAN DIEGO--(BUSINESS WIRE)--Aries Pharmaceuticals, Inc. (Aries), a specialty pharmaceutical company commercializing best-in-class gastroenterology products utilized in endoscopy and for the treatment ...
Aries Pharmaceuticals launched its submucosal injectable composition Eleview. Here's what you should know. 1. Eleview allows providers to remove polyps, adenomas, early stage cancers and other lesions ...
Dublin, December 2, 2019 - Cosmo Pharmaceuticals NV (SIX: COPN) announced today that it has entered into a new worldwide supply and distribution agreement for Eleview with Medtronic (with the ...
Cosmo Pharmaceuticals N.V. / Key word(s): Miscellaneous COSMO ANNOUNCES EXPANDING THE AGREEMENT WITH MEDTRONIC FOR ELEVIEW(R) TO ALL COUNTRIES EXCEPT CANADA 03.05.2022 / 06:00 Dublin, Ireland - 3 May ...
A Hong Kong-based fund manager is launching a new hedge fund to tap rising investor interest in Asian artificial intelligence stocks, with a focus on Taiwan and Japan, three sources familiar with the ...
In a recent press release from Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today ...
Here’s what you should know. 1. Eleview allows providers to remove polyps, adenomas, early stage cancers and other lesions in the gastrointestinal tract. 2. Cosmo Pharmaceuticals developed Eleview.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results